The DEA begins reviewing its proposal to move cannabis to Schedule III, even as reform advocates criticize their exclusion ...

Last December, President Trump signed an executive order calling for the rescheduling of marijuana. The DEA is now ...

This is read by an automated voice. Please report any issues or inconsistencies here. An experimental medication made from marijuana successfully reduced back pain in a new study, offering further ...

Researchers recently found cannabis can trigger psychosis that may be different from schizophrenia or could be similar. Ending or decreasing cannabis use may improve the condition.

As the U.S. Drug Enforcement Administration (DEA) gears up for its administrative hearing on the fate of federal marijuana ...

Sara Dorn is a Forbes news reporter who covers politics. President Donald Trump said his administration is considering reclassifying marijuana as a less serious drug, appeasing industry lobbyists and ...

President Trump has signaled he’s considering correcting a 50-year mistake in US drug laws: Marijuana is in the same category as heroin and LSD. A change in pot’s legal status at the federal level is ...

A German study found a marijuana-based drug reduced chronic back pain. The low-dose THC formula improved pain, sleep, and function. Researchers say it could be a safer alternative to opioids.

See more of our coverage in your search results. Add The New York Post on Google You know it’s a bad idea if Joe Biden was for it. That’s the case with the mad push for marijuana reform, which Biden ...

SEATTLE — President Donald Trump’s decision to reclassify state-licensed medical marijuana as a less dangerous drug is a boon for the industry: It gives dispensaries a big tax break, eases some ...

A secret government study has found that more than half of medical cannabis users are misusing their medication, including by ...